| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |